TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research June 27, 1997
TCL Archive Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer November 1, 2012